Teaching pixels to predict the future
Quibim’s platform now analyses medical imaging at over 190 sites globally. Its algorithms stage liver fibrosis, grade osteoarthritis, quantify tumour heterogeneity, and—most provocatively—predict genetic mutations from routine imaging.
“When you measure the standalone performance of those algorithms right now, they are equally comparable, if not superior to radiologists.” Normal studies are waved through automatically; specialists focus on the edge cases.
Emails arrive from grateful families: “Patients, coming to us saying, well, my cancer was detected by your AI, being so grateful.”
Culture as competitive software
Inside the company, Ángel laminated lessons from Juan Roig and aviation’s just‑culture into an operating manual.
Mistakes trigger open de‑briefs, not finger‑pointing: is this a gap in training, a broken process, an unclear SOP? Issues aren’t swept under the carpet; they become tickets, fixes, and eventually standard operating procedure.
Turnover remains low; ownership runs high.
‘The revolution in healthcare will come from patients’
For all the regulatory wins and hospital contracts, Ángel insists that true disruption won’t originate inside institutions. “The revolution in healthcare will come from patients. It will not come from governments.”
He envisions individuals owning lifetime image archives, querying AI for second opinions, and donating anonymised data to sharpen future models. In that world radiologists evolve from fire‑fighters to flight controllers—monitoring dashboards of algorithmic alerts, intervening where it counts.
Out‑gunning the Goliaths
Quibim now goes head‑to‑head with OEMs that build both the scanners and the software, yet the startup punches above its weight.
A recent FDA 510(k) clearance for QP-prostate arrived early in 2025, which aims to increase diagnostic accuracy and early detection of prostate cancer. Ángel credits these wins to culture: small, trusted teams ship sooner; the just‑culture catches errors before regulators do.
Ten more ideas taped above a desk
A decade in, Ángel still keeps building—now inside Quibim’s Valencia headquarters. While he’s kept busy with the CEO‑work of budgets and board decks; he still finds time for “ten more ideas” to improve healthcare management and push non‑invasive diagnostics deeper.
“The mission is trying to detect disease early, to diagnose better, to be able to give the right treatment to the right patient at the right time.”
Ángel is pushing for imaging to be used earlier, in screening. This approach has been proven to save many women from breast cancer. He builds on the same belief that began with a Game Boy ECG: the body is broadcasting. All we have to do, is listen.
“I’ve always been captivated by trying to understand everything happening at every single tissue point of our human body.”
That obsession, born in a town better known for oranges than algorithms, is now teaching pixels to whisper secrets—long before disease has its say.